EGFR and head and neck squamous cell carcinoma: Similarly, in head and neck squamous cell carcinoma (HNSCC), CAFs promote resistance to EGFR inhibitors through the secretion of Matrix Metalloproteinases (MMPs) and Amphiregulin (AREG)-mediated receptor stabilization [172].